The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Oxidized LDL and Malondialdehyde-Modified LDL in Patients With Acute Coronary Syndromes and Stable Coronary Artery Disease
Open accessAbstract
Background —The association between oxidative modifications of LDL and coronary artery disease (CAD) is suspected but not established. Therefore, the association between plasma levels of oxidized LDL and malondialdehyde (MDA)-modified LDL and acute coronary syndromes and stable CAD was investigated. Methods and Results —The study population contained 63 patients with acute coronary syndromes (45 with acute myocardial infarction and 18 with unstable angina pectoris), 35 nontransplanted patients with angiographically confirmed stable angina, 28 heart transplant patients with posttransplant CAD, 79 heart transplant patients without CAD, and 65 control subjects. After correction for age, sex, and LDL and HDL cholesterol, plasma levels of oxidized LDL and MDA-modified LDL were significantly higher in patients with CAD than in individuals without CAD ( r 2 =0.57 and r 2 =0.26, respectively; both P =0.0001). Plasma levels of MDA-modified LDL were significantly higher in patients with acute coronary syndromes than in individuals with stable CAD ( r 2 =0.65; P =0.0001) and were associated with increased levels of troponin I and C-reactive protein ( r 2 =0.39 and r 2 =0.34, respectively; both P =0.0001). Plasma levels of oxidized LDL were not associated with increased levels of troponin I and C-reactive protein ( r 2 =0.089 and r 2 =0.063, respectively). Conclusions —Elevated plasma levels of oxidized LDL are associated with CAD. Elevated plasma levels of MDA-modified LDL suggest plaque instability and may be useful for the identification of patients with acute coronary syndromes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,760
LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
Brown, M. S., & Goldstein, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001255 · Cited by 2,300
Antman, E. M., Tanasijevic, M. J., Thompson, B., Schactman, M., McCabe, C. H., Cannon, C. P., Fischer, G. A., Fung, A. Y., Thompson, C., Wybenga, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351802 · Cited by 1,749
Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L., & Steinberg, D. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3883 · Cited by 1,626
Rg, G. (1981) · PubMed Central · Cited by 1,314
Cardiac troponin I. A marker with high specificity for cardiac injury.
Adams, J. E., Bodor, G. S., Dávila-Román, V. G., Delmez, J. A., Apple, F. S., Ladenson, J. H., & Jaffe, A. S. (1993) · Circulation · doi:10.1161/01.cir.88.1.101 · Cited by 1,148
Fogelman, A. M., Shechter, I., Seager, J., Hokom, M., Child, J. S., & Edwards, P. A. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.4.2214 · Cited by 849
Esterbauer, H., Jürgens, G., Quehenberger, O., & Koller, E. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38678-8 · Cited by 766
Lewis A. Conner Memorial Lecture: Oxidative Modification of LDL and Atherogenesis
Steinberg, D. (1997) · Circulation · doi:10.1161/01.cir.95.4.1062 · Cited by 748
Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.
Morrow, J. D., Awad, J. A., Boss, H. J., Blair, I. A., & Roberts, L. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10721 · Cited by 735
Steinbrecher, U. P. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61395-x · Cited by 615
Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages.
Schaffner, T., Taylor, K., Bartucci, E. J., Fischer-Dzoga, K., Beeson, J. H., Glagov, S., & Wissler, R. W. (1980) · PubMed · Cited by 476
A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.
Parthasarathy, S., Wieland, E., & Steinberg, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.1046 · Cited by 415
Savenkova, M. L., Mueller, D. M., & Heinecke, J. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32005-7 · Cited by 335
Oxidative Modification of LDL and Atherogenesis
Steinberg, D. (1998) · Medical Science Symposia Series · doi:10.1007/978-94-011-5022-4_16 · Cited by 329
Heery, J. M., Kozak, M., Stafforini, D. M., Jones, D. A., Zimmerman, G. A., McIntyre, T. M., & Prescott, S. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118288 · Cited by 306
Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins.
Haberland, M. E., Fogelman, A. M., & Edwards, P. A. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.6.1712 · Cited by 274
Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.
Holvoet, P., Perez, G., Zhao, Z., Brouwers, E., Bernar, H., & Collen, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117963 · Cited by 262
Self-citationLipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques.
Folcik, V. A., Nivar-Aristy, R. A., Krajewski, L. P., & Cathcart, M. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118062 · Cited by 252
Lynch, S. M., Morrow, J. D., Roberts, L. J., & Frei, B. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117107 · Cited by 236
Haberland, M. E., Olch, C. L., & Folgelman, A. M. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90863-x · Cited by 211
Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages.
Hoff, H. F., O'Neil, J., Chisolm, G. M., Cole, T. B., Quehenberger, O., Esterbauer, H., & Jürgens, G. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.4.538 · Cited by 189
Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?
Steinberg, D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92657-7 · Cited by 178
Holvoet, P., Donck, J., Landeloos, M., Brouwers, E., Luijtens, K., Arnout, J., Lesaffre, E., Vanrenterghem, Y., & Collen, D. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650639 · Cited by 178
Self-citationOxidized Low Density Lipoproteins in Patients With Transplant-Associated Coronary Artery Disease
Holvoet, P., Stassen, J.-M., Van Cleemput, J., Collen, D., & Vanhaecke, J. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.1.100 · Cited by 177
Self-citationSecretory group II phospholipase A2 in human atherosclerotic plaques
Menschikowski, M., Kasper, M. E., Lattke, P., Schiering, A., Schiefer, S., Stockinger, H., & Jaroß, W. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05604-1 · Cited by 130
Thrombosis and atherosclerosis
Holvoet, P., & Collen, D. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199710000-00012 · Cited by 125
Self-citationOxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro.
Murugesan, G., Chisolm, G. M., & Fox, P. L. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.120.4.1011 · Cited by 115
Holvoet, P., Theilmeier, G., Shivalkar, B., Flameng, W. J., & Collen, D. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.3.415 · Cited by 115
Self-citationCellular oxidative modification of low density lipoprotein does not require lipoxygenases.
Sparrow, C. P., & Olszewski, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.128 · Cited by 98
Hammer, A., Kager, G., Dohr, G., Rabl, H., Ghassempur, I., & Jürgens, G. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.5.704 · Cited by 78
Cardiac Troponins in Acute Coronary Syndromes
de Werf, F. V. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351809 · Cited by 39
Holvoet, P., & Collen, D. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2376 · Cited by 36
Self-citationMenschikowski, M., Kasper, M., Lattke, P., Schiering, A., & Jaroß, W. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)96350-2 · Cited by 25
Aviram, M., & Maor, I. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116413 · Cited by 24
C-Reactive Protein and Serum Amyloid a Protein in Unstable Angina
Ryan, J., Ward, M., & Sama, A. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502093320614 · Cited by 10
Cited by
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611
Biological markers of oxidative stress: Applications to cardiovascular research and practice
Ho, E., Karimi Galougahi, K., Liu, C.-C., Bhindi, R., & Figtree, G. A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.07.006 · Cited by 811
Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease
Tsimikas, S., Brilakis, E. S., Miller, E. R., McConnell, J. P., Lennon, R. J., Kornman, K. S., Witztum, J. L., & Berger, P. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043175 · Cited by 784
Ehara, S., Ueda, M., Naruko, T., Haze, K., Itoh, A., Otsuka, M., Komatsu, R., Matsuo, T., Itabe, H., Takano, T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.15.1955 · Cited by 781
Metadata
- Authors
- Holvoet, P., Vanhaecke, J., Janssens, S., Van de Werf, F., & Collen, D.
- Venue
- Circulation
- Published
- 1998-10-13
- Volume
- 98
- Issue
- 15
- Pages
- 1487-1494
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2122115743
- Cited by
- 673
- References
- 37
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.